Lu Ziwei, You Zhiqun, Xie Daohai, Wang Zhongling
Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Technol Health Care. 2019;27(2):137-147. doi: 10.3233/THC-181447.
It is difficult to distinguish solitary of fibrous tumor/hemangiopericytoma (SFT/HPC) from atypical meningioma (AM) by conventional imaging.As far as we know,diffusion weighting imaging may identify them effectively.
The purpose of this study was to determine the role of apparent diffusion coefficient (ADC) values to distinguish and predict prognosis of solitary of fibrous tumor/hemangiopericytoma (SFT/HPC) (WHOII) and atypical meningioma (AM).
Preoperative diffusion-weighted imaging (DWI) of 30 cases with histopathologic and immunhistochemical testified SFT/HPC WHOII (n= 11) and AM (n= 19) were performed retrospectively. The ADC values of lesion, peritumoral edema, normal white matter and lesion NADC ratio (lesion ADC values/ADC values of normal white matter (NWN ADC)) were compared. The immunhistochemical markers (Ki-67, CD34, Vim, EMA, GFAP, S-100, PR, CD56) were compared. The correlation between the ADC values and Ki-67 index was evaluated.
The mean lesion ADC values of SFT/HPC (1.15 ± 0.04 × 10-3 mm2/s) was significantly higher than that of AM (0.80 ± 0.04 × 10-3 mm2/s) (t= 23.824, p< 0.05). The mean NADC ratio was lower for AM (1.03 ± 0.06) compared with SFT/HPC (1.51 ± 0.05) (t= 23.105, p< 0.05). The mean edema ADC for SFT/HPC (1.47 ± 0.06 × 10-3 mm2/s) was lower compared with AM (1.68 ± 0.05 × 10-3 mm2/s) (t=-9.926, p< 0.05 ). There was no statistical difference between the two groups of NWM ADC (t=-1.475, p> 0.05) . The mean Ki-67 of SFT/HPC (7.18 ± 2.60%) was lower than the mean Ki-67 of AM (13.58 ± 4.50%) (t=-4.934, p< 0.05). The CD34 showed statistically differences between two groups (X2= 13.659, p< 0.05). The EMA also showed statistically differences between two groups (X2= 4.474, p< 0.05). Vim,GFAP, S-100, PR, CD56 showed no statistical difference in the two group (p> 0.05). The pearson analysis indicated that there was a negative correlation between lesion ADC and Ki-67 in SFT/HPC group (r=-0.770, p< 0.05) and AM group (r=-0.727, p< 0.05). There was also a negative correlation between lesion NADC ratio and Ki-67 in SFT/HPC group (r=-0.673, p< 0.05) and AM group (r=-0.707, p< 0.05). There was a positive correlation between edema ADC and Ki-67 in SFT/HPC group (r= 0.819, p< 0.05) and AM group (r= 0.942, p< 0.05). Furthermore,there was no correlation between NWM A DC and Ki-67 in SFT/HPC group (r=-0.403, p> 0.05) and AM group (r= 0.202, p> 0.05).
The lesion ADC, lesion NADC ratio and edema ADC can distinguish the SFT/HPC WHO II from AM and be helpful to predict prognosis of the two tumors before operation. Further more, histopathologic and immunhistochemical can make a definite diagnosis of the two tumors.
通过传统影像学检查很难将孤立性纤维瘤/血管外皮细胞瘤(SFT/HPC)与非典型脑膜瘤(AM)区分开来。据我们所知,弥散加权成像可能有助于有效鉴别这两种肿瘤。
本研究旨在确定表观扩散系数(ADC)值在鉴别孤立性纤维瘤/血管外皮细胞瘤(SFT/HPC,WHO II级)和非典型脑膜瘤(AM)以及预测其预后方面的作用。
回顾性分析30例经组织病理学和免疫组织化学证实的SFT/HPC WHO II级(n = 11)和AM(n = 19)患者的术前弥散加权成像(DWI)资料。比较病变、瘤周水肿、正常白质的ADC值以及病变NADC比值(病变ADC值/正常白质ADC值(NWN ADC))。比较免疫组织化学标志物(Ki-67、CD34、波形蛋白、上皮膜抗原、胶质纤维酸性蛋白、S-100、孕激素受体、CD56)。评估ADC值与Ki-67指数之间的相关性。
SFT/HPC的平均病变ADC值(1.15±0.04×10⁻³mm²/s)显著高于AM(0.80±0.04×10⁻³mm²/s)(t = 23.824,p < 0.05)。与SFT/HPC(1.51±0.05)相比,AM的平均NADC比值较低(1.03±0.06)(t = 23.105,p < 0.05)。SFT/HPC的平均水肿ADC值(1.47±0.06×10⁻³mm²/s)低于AM(1.68±0.05×10⁻³mm²/s)(t = -9.926,p < 0.05)。两组正常白质ADC值无统计学差异(t = -1.475,p > 0.05)。SFT/HPC的平均Ki-67(7.18±2.60%)低于AM的平均Ki-67(13.58±4.50%)(t = -4.934,p < 0.05)。CD34在两组间有统计学差异(X² = 13.659,p < 0.05)。上皮膜抗原在两组间也有统计学差异(X² = 4.474,p < 0.05)。波形蛋白、胶质纤维酸性蛋白、S-100、孕激素受体、CD56在两组间无统计学差异(p > 0.05)。Pearson分析表明,SFT/HPC组和AM组中病变ADC与Ki-67均呈负相关(SFT/HPC组:r = -0.770,p < 0.05;AM组:r = -0.727,p < 0.05)。SFT/HPC组和AM组中病变NADC比值与Ki-67也呈负相关(SFT/HPC组:r = -0.673,p < 0.05;AM组:r = -0.707,p < 0.05)。SFT/HPC组和AM组中水肿ADC与Ki-67呈正相关(SFT/HPC组:r = 0.819,p < 0.05;AM组:r = 0.942,p < 0.05)。此外,SFT/HPC组和AM组中正常白质ADC与Ki-67无相关性(SFT/HPC组:r = -0.403,p > 0.05;AM组:r = 0.202,p > 0.05)。
病变ADC值、病变NADC比值及水肿ADC值可用于鉴别SFT/HPC WHO II级与AM,并有助于术前预测两种肿瘤的预后。此外,组织病理学和免疫组织化学检查可明确诊断这两种肿瘤。